Position in ELTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$170,804 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
11 quarters on record
Common Shares in ELTX Over Time
Shares Held
Position Value (USD)
Derivatives in ELTX
reported options exposure · as of Jun 30, 2026CallValue
$524,722
CallShares
134,200
PutValue
$58,650
PutShares
15,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in ELTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $524,722 | 134,200 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $58,650 | 15,000 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $179,592 | 16,800 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $484,257 | 45,300 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $170,804 | 15,978 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $280,192 | 35,200 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $146,464 | 18,400 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $229,740 | 21,000 | Call | Defined | 2025-11-14 | |
| 2024-09-30 | $64,665 | 12,856 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $116,801 | 14,005 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $136,940 | 16,206 | Shares | Defined | 2023-11-14 | |
| 2022-09-30 ANGN | — | 14,675 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 ANGN | — | 60,158 | Shares | Defined | 2022-08-15 | |
| 2021-06-30 ANGN | — | 23,864 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ANGN | — | 34,956 | Shares | Defined | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||